373 related articles for article (PubMed ID: 28765228)
21. PET/CT Evaluation of Cardiac Sarcoidosis.
Bois JP; Muser D; Chareonthaitawee P
PET Clin; 2019 Apr; 14(2):223-232. PubMed ID: 30826020
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
[TBL] [Abstract][Full Text] [Related]
23. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
[TBL] [Abstract][Full Text] [Related]
25. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
Lu Y; Grant C; Xie K; Sweiss NJ
Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
[TBL] [Abstract][Full Text] [Related]
26. Monitoring the Therapy of Extensive Osseous Sarcoidosis With FDG PET/CT.
Yang H; Numani S; Liu S
Clin Nucl Med; 2017 Jul; 42(7):e337-e339. PubMed ID: 28240658
[TBL] [Abstract][Full Text] [Related]
27. Proliferation imaging with
Minamimoto R; Hotta M; Hiroe M; Awaya T; Nakajima K; Okazaki O; Yamashita H; Kaneko H; Hiroi Y
J Nucl Cardiol; 2021 Apr; 28(2):752-755. PubMed ID: 32052294
[No Abstract] [Full Text] [Related]
28. 11C-4DST PET/CT Imaging of Cardiac Sarcoidosis: Comparison With 18F-FDG and Cardiac MRI.
Hotta M; Minamimoto R; Kubota S; Awaya T; Hiroi Y
Clin Nucl Med; 2018 Jun; 43(6):458-459. PubMed ID: 29538030
[TBL] [Abstract][Full Text] [Related]
29. Recurrent ventricular tachycardia in cardiac sarcoidosis: usefulness of fluorodeoxyglucose positron emission tomography for adequate management of corticoid therapy after placement of an implantable cardioverter defibrillator.
Casset-Senon D; Philippe L; Renard JP; Cosnay P
J Nucl Cardiol; 2008; 15(2):282-5. PubMed ID: 18371601
[No Abstract] [Full Text] [Related]
30. FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab.
Miller CT; Sweiss NJ; Lu Y
Clin Nucl Med; 2016 May; 41(5):417-8. PubMed ID: 26828145
[TBL] [Abstract][Full Text] [Related]
31. Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
John LA; Tedrow UB; Divakaran S
J Nucl Cardiol; 2023 Dec; 30(6):2501-2503. PubMed ID: 37474748
[No Abstract] [Full Text] [Related]
32. Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis.
Tang R; Wang JT; Wang L; Le K; Huang Y; Hickey AJ; Emmett L
Clin Nucl Med; 2016 Jul; 41(7):e327-39. PubMed ID: 26646995
[TBL] [Abstract][Full Text] [Related]
33. Serial assessment of cardiac involvement in sarcoidosis by delayed
Aikawa T; Manabe O; Ibe T; Oyama-Manabe N
J Nucl Cardiol; 2023 Oct; 30(5):2225-2228. PubMed ID: 36443590
[No Abstract] [Full Text] [Related]
34. Expert Consensus on clinical application of FDG PET/CT in infection and inflammation.
Li Y; Wang Q; Wang X; Li X; Wu H; Wang Q; Yao Z; Miao W; Zhu X; Hua F; Zhang X; Cheng C; Zhang W; Hou Q; Li Y; Li XF
Ann Nucl Med; 2020 May; 34(5):369-376. PubMed ID: 32086761
[TBL] [Abstract][Full Text] [Related]
35. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
36. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.
Slart RHJA; Glaudemans AWJM; Lancellotti P; Hyafil F; Blankstein R; Schwartz RG; Jaber WA; Russell R; Gimelli A; Rouzet F; Hacker M; Gheysens O; Plein S; Miller EJ; Dorbala S; Donal E;
J Nucl Cardiol; 2018 Feb; 25(1):298-319. PubMed ID: 29043557
[No Abstract] [Full Text] [Related]
37. Undiagnosed cardiac sarcoidosis presenting as complete heart block and ventricular arrhythmia.
Mcbeath K; Honarbakhsh S; Chowdhury M; Farooqi F
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26282455
[TBL] [Abstract][Full Text] [Related]
38. How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body
Juneau D; Nery P; Russo J; de Kemp RA; Leung E; Beanlands RSB; Birnie DH
Int J Cardiol; 2018 Feb; 253():189-193. PubMed ID: 29306462
[TBL] [Abstract][Full Text] [Related]
39. FDG PET-CT findings of extra-thoracic sarcoid are associated with cardiac sarcoid: A rationale for using FGD PET-CT for cardiac sarcoid evaluation.
Patel DC; Gunasekaran SS; Goettl C; Sweiss NJ; Lu Y
J Nucl Cardiol; 2019 Apr; 26(2):486-492. PubMed ID: 28681340
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
